The Scientist

» patent and neuroscience

Most Recent

image: Hormone Hangover

Hormone Hangover

By | February 1, 2016

Medication to prevent prematurity in humans harms cognitive flexibility in rats.

0 Comments

image: Infection-Autism Link Explained?

Infection-Autism Link Explained?

By | January 31, 2016

A mouse study suggests a mechanism by which severe infections during pregnancy increase autism risk. 

0 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: More Evidence of Alzheimer’s Transmission

More Evidence of Alzheimer’s Transmission

By | January 27, 2016

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

1 Comment

image: Processing Faces

Processing Faces

By | January 21, 2016

Other people’s faces are mapped onto our brains.

0 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Cocaine Induces Neuronal Autophagy

Cocaine Induces Neuronal Autophagy

By | January 19, 2016

A new study supports the idea that cocaine triggers brain cells to eat themselves and suggests a possible antidote.

2 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

image: How Blasts Affect the Brain

How Blasts Affect the Brain

By | January 13, 2016

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland